Prescient Therapeutics Limited (PTX)
Market Closed
ASX ASX Primary - Market Cap
- P/E Ratio
0.4% Div Yield
173,885 Volume
- Eps
Want to track PTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
PTX Earnings Reports FAQ
What is the earnings per share (EPS) for PTX?
EPS data for PTX is currently not available, as Prescient Therapeutics Limited has not reported recent earnings.
What is the company's earnings growth rate?
Prescient Therapeutics Limited has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Prescient Therapeutics Limited has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Prescient Therapeutics Limited are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for PTX at this time, as Prescient Therapeutics Limited has no recent EPS data to calculate it.
